US 10301369
Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins
granted A61KA61K38/00A61K38/47
Quick answer
US patent 10301369 (Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins) held by BIOMARIN PHARMACEUTICAL INC. expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61K38/47, A61P, A61P3/00